Use of long‐acting cabotegravir and rilpivirine in people living with HIV : A prospective observational cohort study

Documenti analoghi

• Long‐acting cabotegravir and rilpivirine in people with HIV and obesity: Real‐world outcomes from the RELATIVITY cohort
  di: Jesús Troya, et al.
  Pubblicazione: (2026)
• Clinical outcomes of long‐acting cabotegravir and rilpivirine in people with HIV aged 60 and older: Real‐world data from the Spanish RELATIVITY cohort
  di: Jesús Troya, et al.
  Pubblicazione: (2025)
• Efficacy of long‐acting cabotegravir plus rilpivirine in viraemic people living with HIV: A systematic review and meta‐analysis
  di: Beatrice Barda, et al.
  Pubblicazione: (2025)
• Long‐acting injectable cabotegravir and rilpivirine in observational cohort studies: A systematic review on virological failure, resistance and re‐suppression outcomes in virally suppressed individuals living with HIV
  di: Kyle Ring, et al.
  Pubblicazione: (2025)
• Real‐world use of long‐acting cabotegravir and rilpivirine: 12‐month results of the inJectable Antiretroviral therapy feasiBility Study (JABS)
  di: M. John, et al.
  Pubblicazione: (2024)